A randomized prospective study of early follicular or midluteal initiation of long protocol gonadotropin-releasing hormone in an in vitro fertilization program
- PMID: 8816620
- DOI: 10.1016/s0015-0282(16)58571-9
A randomized prospective study of early follicular or midluteal initiation of long protocol gonadotropin-releasing hormone in an in vitro fertilization program
Abstract
Objective: To determine the optimum menstrual cycle time to initiate a long-protocol gonadotropin-releasing hormone agonist (GnRH-a) down-regulation regimen before hMG stimulation before IVF.
Design: Randomized, prospective, single, first cycle study.
Setting: University teaching hospital.
Patients: Eighty-six infertile couples undergoing IVF-ET attempt under rules for Ireland.
Intervention: Gonadotropin-releasing hormone agonist administered intranasally from day 1 or 21 of menstrual cycle. Human menopausal gonadotropin commenced when pituitary down-regulation was confirmed.
Main outcome measures: Ovarian response, cancellation, fertilization, and pregnancy rates.
Results: No significant differences found between day 1 and day 21 initiation. But starting on day 1 is more easily recognizable by patients and avoids the possibility of administering GnRH-a in the presence of an unsuspected pregnancy.
Conclusions: Both follicular and luteal phase initiation of GnRH-a long-protocol down-regulation are equally efficacious. In our clinical context, patients and management favor commencing on day 1.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources